PRRT2 and kidney disorder: Therefore, further pre‐clinical and clinical studies are now invited to uncover whether the targeted manipulation of activities of certain PKC isoforms might be beneficial in the therapeutic management of given proteinuric kidney diseases with altered TRPC6 functions.